Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A23544 | 23695216 | Am J Physiol Endocrinol Metab | Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. | 2013 | Details |
A23546 | 23692373 | Diabet Med | Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation. | 2013 | Details |
A23549 | 23691267 | Oxid Med Cell Longev | Increased nitroxidative stress promotes mitochondrial dysfunction in alcoholic and nonalcoholic fatty liver disease. | 2013 | Details |
A23551 | 23690766 | Int J Endocrinol | Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. | 2013 | Details |
A23552 | 23688357 | Cardiovasc Diabetol | Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study. | 2013 | Details |
A23553 | 23688034 | BMC Med Genet | Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver. | 2013 | Details |
A23558 | 23678860 | J Dig Dis | Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico. | 2013 | Details |
A23559 | 23676586 | Intern Med | Effects of liraglutide, a human glucagon-like peptide-1 analogue, on body weight, body fat area and body fat-related markers in patients with type 2 diabetes mellitus. | 2013 | Details |
A23563 | 23671723 | World J Hepatol | CD14 upregulation as a distinct feature of non-alcoholic fatty liver disease after pancreatoduodenectomy. | 2013 | Details |
A23567 | 23668723 | Proc Nutr Soc | Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. | 2013 | Details |
A23569 | 23666091 | Nutrients | Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. | 2013 | Details |
A23570 | 23665288 | J Hepatol | A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. | 2013 | Details |
A23574 | 23663767 | Zhonghua Gan Zang Bing Za Zhi | [Effects of quercetin on serum levels of resistin and IL-18 and on insulin resistance in nonalcoholic fatty liver disease rats]. | 2013 | Details |
A23580 | 23659066 | Klin Med (Mosk) | [Low and very low density lipoproteins: pathogenetic and clinical significance]. | 2013 | Details |
A23584 | 23656726 | Br J Nutr | Effects of long-term administration of saturated and n-3 fatty acid-rich diets on lipid utilisation and oxidative stress in rat liver and muscle tissues. | 2013 | Details |
A23588 | 23653642 | Int J Endocrinol | Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. | 2013 | Details |
A23593 | 23651850 | Am J Physiol Endocrinol Metab | Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. | 2013 | Details |
A23598 | 23643404 | Metabolism | Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. | 2013 | Details |
A23599 | 23642511 | Am J Cardiol | Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
A23604 | 23634670 | Diabetes Technol Ther | Obesity and diabetes: newer concepts in imaging. | 2013 | Details |
A23606 | 23633195 | J Clin Endocrinol Metab | Association of glypican-4 with body fat distribution, insulin resistance, and nonalcoholic fatty liver disease. | 2013 | Details |
A23607 | 23630437 | Int J Med Sci | Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease. | 2013 | Details |
A23609 | 23627940 | Curr Med Chem | Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus. | 2013 | Details |
A23613 | 23626730 | PLoS One | Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. | 2013 | Details |
A23614 | 23626003 | J Clin Endocrinol Metab | Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. | 2013 | Details |
A23627 | 23618531 | J Nutr Biochem | Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice. | 2013 | Details |
A23629 | 23616151 | J Clin Endocrinol Metab | Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease. | 2013 | Details |
A23630 | 23613622 | World J Gastroenterol | Dipeptidyl peptidase-4: a key player in chronic liver disease. | 2013 | Details |
A23638 | 23607264 | Hepatol Res | Efficacy of probucol for the treatment of non-alcoholic steatohepatitis with dyslipidemia: An open-label pilot study. | 2013 | Details |
A23640 | 23603008 | Food Chem Toxicol | Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. | 2013 | Details |
A23642 | 23602473 | Arch Med Res | Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance. | 2013 | Details |
A23643 | 23601769 | Clin Imaging | Importance of the liver ultrasound scores in pubertal obese children with nonalcoholic fatty liver disease. | 2012 | Details |
A23644 | 23601740 | Med Clin (Barc) | [Risk factors associated with non-alcoholic fatty liver disease: a case-control study]. | 2013 | Details |
A23645 | 23600632 | Metab Syndr Relat Disord | Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography. | 2013 | Details |
A23649 | 23597944 | Ann Endocrinol (Paris) | Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: which clinical arguments? | 2013 | Details |
A23651 | 23597726 | Gastroenterology | Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. | 2013 | Details |
A23665 | 23585904 | PLoS One | Fructus Xanthii attenuates hepatic steatosis in rats fed on high-fat diet. | 2013 | Details |
A23667 | 23583988 | Intern Med | An increased circulating angiotensin II concentration is associated with hypoadiponectinemia and postprandial hyperglycemia in men with nonalcoholic fatty liver disease. | 2013 | Details |
A23670 | 23578884 | J Hepatol | Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. | 2013 | Details |
A23674 | 23576902 | ScientificWorldJournal | Current concepts and management approaches in nonalcoholic fatty liver disease. | 2013 | Details |
A23677 | 23569998 | Asian Pac J Trop Biomed | Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease. | 2012 | Details |
A23695 | 23558563 | Dig Dis Sci | Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes. | 2013 | Details |
A23696 | 23558065 | Hepatobiliary Pancreat Dis Int | Therapeutic approaches to non-alcoholic fatty liver disease: past achievements and future challenges. | 2013 | Details |
A23697 | 23557879 | Nutr Metab Cardiovasc Dis | The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. | 2013 | Details |
A23699 | 23556042 | World J Hepatol | Silymarin in non alcoholic fatty liver disease. | 2013 | Details |
A23702 | 23554890 | PLoS One | Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. | 2013 | Details |
A23706 | 23548993 | Tumori | Linking nonalcoholic fatty liver disease to hepatocellular carcinoma: from bedside to bench and back. | 2013 | Details |
A23711 | 23546700 | Dig Dis Sci | The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). | 2013 | Details |
A23715 | 23544853 | Metab Syndr Relat Disord | Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. | 2013 | Details |
A23724 | 23534297 | Med Pregl | [Cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease]. | 2013 | Details |
A23725 | 23532271 | Braz J Med Biol Res | Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. | 2013 | Details |
A23728 | 23529597 | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz | [Non-alcoholic fatty liver disease in obese children and adolescents]. | 2013 | Details |
A23732 | 23525389 | J Ultrasound Med | Targeted hepatic sonography during clinic visits for detection of fatty liver in overweight children: a pilot study. | 2013 | Details |
A23734 | 23522007 | Psychol Med | Elevated alanine aminotransferase independently predicts new onset of depression in employees undergoing health screening examinations. | 2013 | Details |
A23741 | 23516571 | PLoS One | Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. | 2013 | Details |
A23742 | 23516172 | World J Gastrointest Pharmacol Ther | Inhibition of apoptosis in the management of nonalcoholic fatty liver disease. | 2013 | Details |
A23745 | 23514731 | Diabetes Care | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. | 2013 | Details |
A23746 | 23512965 | Obesity (Silver Spring) | Metabolomic signatures in lipid-loaded HepaRGs reveal pathways involved in steatotic progression. | 2013 | Details |
A23747 | 23512881 | Obesity (Silver Spring) | A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. | 2013 | Details |
A23752 | 23510120 | Hepatol Res | Clinical usefulness of non-protein respiratory quotient measurement in non-alcoholic fatty liver disease. | 2013 | Details |
A23758 | 23507799 | Nat Rev Gastroenterol Hepatol | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis. | 2013 | Details |
A23762 | 23504985 | Pediatr Obes | Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. | 2013 | Details |
A23763 | 23504926 | Hepatology | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). | 2013 | Details |
A23775 | 23492103 | Gut | Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. | 2013 | Details |
A23778 | 23488792 | J Gastroenterol Hepatol | Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice. | 2013 | Details |
A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
A23786 | 23482247 | World J Gastroenterol | Fructose as a key player in the development of fatty liver disease. | 2013 | Details |
A23791 | 23478717 | Nutr Hosp | Influence of G1359A polimorphysm of the cannabinoid receptor gene (CNR1) on insulin resistance and adipokines in patients with non alcoholic fatty liver disease. | 2013 | Details |
A23792 | 23478246 | Minerva Gastroenterol Dietol | Liver steatosis in celiac disease: the open door. | 2013 | Details |
A23793 | 23478245 | Minerva Gastroenterol Dietol | Management of non-alcoholic fatty liver disease. | 2013 | Details |
A23795 | 23477499 | Antioxid Redox Signal | Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. | 2013 | Details |
A23801 | 23466642 | Horm Res Paediatr | Nonalcoholic fatty liver disease in prepubertal children born small for gestational age: influence of rapid weight catch-up growth. | 2013 | Details |
A23806 | 23458891 | Nat Rev Gastroenterol Hepatol | NAFLD in Asia--as common and important as in the West. | 2013 | Details |
A23812 | 23453039 | Metabolism | Involvement of regucalcin in lipid metabolism and diabetes. | 2013 | Details |
A23813 | 23452341 | Br J Clin Pharmacol | The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. | 2014 | Details |
A23814 | 23452186 | Clin Microbiol Infect | Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota? | 2013 | Details |
A23817 | 23451176 | PLoS One | Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. | 2013 | Details |
A23827 | 25755466 | J Clin Exp Hepatol | Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis. | 2012 | Details |
A23834 | 23439771 | Diabetes Metab J | Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease. | 2013 | Details |
A23836 | 23439261 | J Hepatol | The liver diseases of lipodystrophy: the long-term effect of leptin treatment. | 2013 | Details |
A23840 | 23433458 | Adv Pharmacol | Eicosanoids in metabolic syndrome. | 2013 | Details |
A23841 | 23432982 | Arab J Gastroenterol | Relationship between non-alcoholic fatty liver disease and kidney function: a communication between two organs that needs further exploration. | 2012 | Details |
A23842 | 23432843 | Liver Int | GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK. | 2013 | Details |
A23846 | 23431426 | J Obes | Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? | 2013 | Details |
A23847 | 23431294 | Int J Endocrinol | Hepatic steatosis and thyroid function tests in overweight and obese children. | 2013 | Details |
A23850 | 23430039 | World J Gastroenterol | What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? | 2013 | Details |
A23851 | 23426824 | J Pediatr Endocrinol Metab | Obesity, insulin resistance, and the risk of an elevated alanine aminotransferase activity in the Korean adolescent population. | 2012 | Details |
A23852 | 23426822 | J Pediatr Endocrinol Metab | Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease. | 2012 | Details |
A23854 | 23426707 | Exp Clin Endocrinol Diabetes | Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease. | 2013 | Details |
A23858 | 23424927 | Rev Prat | [Treatment of nonalcoholic steatohepatitis]. | 2012 | Details |
A23861 | 23424924 | Rev Prat | [Epidemiology and natural history of nonalcoholic fatty liver disease]. | 2012 | Details |
A23863 | 23420151 | Clinics (Sao Paulo) | Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. | 2013 | Details |
A23865 | 23419734 | Nutr Metab Cardiovasc Dis | Association of hepatic insulin resistance indexes to nonalcoholic fatty liver disease and related biomarkers. | 2013 | Details |
A23866 | 23419204 | Atherosclerosis | Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. | 2013 | Details |
A23867 | 23418085 | Obesity (Silver Spring) | Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity. | 2013 | Details |
A23881 | 23405890 | Clin Endocrinol (Oxf) | Low serum potassium level is associated with nonalcoholic fatty liver disease and its related metabolic disorders. | 2013 | Details |
A23888 | 23401753 | J Obes | Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. | 2013 | Details |
A23896 | 23397556 | Semin Thromb Hemost | Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. | 2013 | Details |
A23898 | 23397118 | J Gastroenterol | Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. | 2013 | Details |
A23903 | 23394097 | Curr Pharm Des | Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. | 2013 | Details |